Cempra completed a $46 million Series C financing in 2009 2009 which will fund the further development of these compounds.. Cempra commences Phase 2/3 clinical research of CEM-102 for treating acute bacterial skin structure infections Cempra Pharmaceuticals today announced that enrollment is underway in an adaptive design Stage 2/3 clinical research with CEM-102 for patients suffering from acute bacterial skin structure infections .Officials are monitoring the health of 164 people in Ohio who are believed to have had connection with her or to have already been near her. The continuing condition epidemiologist, Dr. Mary DiOrio, wednesday that the monitoring of the 164 should end Nov said during a telephone news conference. 4. Officials once again emphasized that nobody in Ohio shows symptoms of the disease. Obviously it’s been a stressful period for those being monitored, DiOrio stated.
As feds encourage health IT, analysts forecast big upsurge in telehealth Politico and The Hill covered various aspects of electronic health information and health care. Politico: Feds; 'E-Health' Initiative Gets to Out To Patients In a day and age of the net, Wi-Fi and ever-present public media, so-called e-health lags far behind.